ST PHARM to Expand Oligonucleotide Facility — ST PHARM

Science & Technology
- Business Overview
- CDMO
- CRO
  - AnaPath Research & Service
- R&D
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG
- Update in progress

Sitemap

Linkedin

Public

All

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

All

Nov 29, 2021

ST PHARM to Expand Oligonucleotide Facility

Will invest $126 million thru 2025 in second oligonucleotide plant with four to six large production lines.

[Source]
https://www.contractpharma.com/contents/view_breaking-news/2021-11-29/st-pharm-to-expand-oligonucleotide-facility/